Ayar Labs Secures $35 Million in Series B Funding and Adds New Strategic and Global Investors as Interest in Optical Interconnect Grows
There may be hope on the horizon for men who want to have more agency over birth control: YCT-529, a drug candidate that aims to be the first non-hormonal contraceptive pill for men.
